Learn about the global breast cancer diagnostics market through The Business Research Company, which provides information on breast cancer diagnostics market size, breast cancer diagnostics market drivers and restraints, breast cancer diagnostics market players, the COVID-19 impact on the breast cancer diagnostics market, and more.

The global breast cancer diagnostics market size is expected to grow from $3.75 billion in 2021 to $4.06 billion in 2022 at a compound annual growth rate (CAGR) of 8.3%. The global breast cancer diagnostic market is then expected to grow to $5.48 billion in 2026 at a CAGR of 7.8%.

The increasing incidence of breast cancer will require more equipment to diagnose, which will further increase the demand for the breast cancer diagnostics market.

Request A Sample For The Global Breast Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

The breast cancer diagnostics market consists of sales of breast cancer diagnostic devices and related services by entities (organizations, sole traders, and partnerships) that produce breast cancer diagnostics devices. These devices are used to diagnose breast cancer. Only goods and services traded between entities or sold to end consumers are included.

Global Breast Cancer Diagnostics Market Segments Include:

By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Others

By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Others

By Cancer Type: BRCA Breast Cancer, ER and PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Others

By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-Ionizing Imaging Technologies

By End-User: Hospitals and Clinics, Cancer Research Centres, Diagnostic Laboratories, Ambulatory Surgical Centres.

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the breast cancer diagnostics market in 2021.

Technological advancement is a key trend in the breast cancer diagnostics market. Several new techniques have been developed which could be used in the diagnosis and treatment of breast cancer. The 3D mammography, also known as breast tomosynthesis, takes photographs around the breast from various angles and translates them into a 3-D model.

TBRC’s breast cancer diagnostics market report covers:

Major Market Players: Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V, Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-2021) and ten years forecast (2022-2026-2031)

The Breast Cancer Diagnostics Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides breast cancer diagnostics market overviews, analyzes and forecasts market size, share, breast cancer diagnostics market players, breast cancer diagnostics market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s breast cancer diagnostics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Breast Imaging Devices Market 2022

Breast Cancer Monoclonal Antibodies Global Market Report 2022

Cancer Clinical Decision Tools Global Market Report 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: